These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia. Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332 [TBL] [Abstract][Full Text] [Related]
12. Therapy-induced Deletion in 11q23 Leading to Fusion of Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897 [TBL] [Abstract][Full Text] [Related]
13. An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in Wang H; Shah CA; Hu L; Huang W; Platanias LC; Eklund EA J Biol Chem; 2020 Jul; 295(28):9663-9675. PubMed ID: 32467231 [TBL] [Abstract][Full Text] [Related]
14. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. Heikamp EB; Henrich JA; Perner F; Wong EM; Hatton C; Wen Y; Barwe SP; Gopalakrishnapillai A; Xu H; Uckelmann HJ; Takao S; Kazansky Y; Pikman Y; McGeehan GM; Kolb EA; Kentsis A; Armstrong SA Blood; 2022 Feb; 139(6):894-906. PubMed ID: 34582559 [TBL] [Abstract][Full Text] [Related]
15. Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Nguyen D; Kantarjian HM; Short NJ; Qiao W; Ning J; Cuglievan B; Daver NG; DiNardo CD; Jabbour EJ; Kadia TM; Borthakur G; Garcia-Manero G; Konopleva MY; Andreeff M; Ravandi-Kashani F; Sasaki K; Issa GC Cancer; 2023 Jun; 129(12):1856-1865. PubMed ID: 36892949 [TBL] [Abstract][Full Text] [Related]
16. Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute Leukemia. Yin L; Wan L; Zhang Y; Hua S; Shao X Cancer Med; 2024 Oct; 13(20):e70326. PubMed ID: 39428967 [TBL] [Abstract][Full Text] [Related]